Science
DeepMind's AlphaGenome 2 predicts what DNA variants do cell by cell. What it can do, who can use it, and its limits
Google DeepMind's second-generation genome model predicts how a DNA change affects a specific cell type rather than a tissue average, and says it finds nearly twice as many expression-changing variants as before. It's free for non-commercial research through an API today, but it still misses most causal variants and isn't for clinical use.